|
| |
CardioMPO Pages on BioPortfolio:
BioPortfolio - PrognostiX, Inc.
PrognostiX is marketing the CardioMPO™ ELISA based test kit for in vitro diagnostic use. The CardioMPO™ Test measures myeloperoxidase (MPO) levels in
human ...
http://www.bioportfolio.com/biocorporate/28683-PrognostiX,_I...
|
BioPortfolio - Syncro Medical Innovations, Inc - Profile
Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test. Therapeutics Daily: Nov 13 2008 10:25PM Matching: medical
...
http://www.bioportfolio.com/biocorporate/23226-Syncro+Medica...
|
BioPortfolio - Syncro Medical Innovations, Inc - Profile
Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO Test. MDLinx: Nov 8 2008 4:00AM Matching: medical innovations inc ...
http://www.bioportfolio.com/biocorporate/23226-Syncro%252BMe...
|
BioPortfolio - PrognostiX, Inc. - Profile
PrognostiX is marketing the CardioMPO™ ELISA based test kit for in vitro ... CardioMPO™ Test measures myeloperoxidase (MPO) levels in human plasma and is ...
http://www.bioportfolio.com/biocorporate/28683-PrognostiX,+I...
|
BioPortfolio - MPO - myeloperoxidase
Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO(TM) Test, KSLA: Nov 4 2008 2:54PM Matching: mpo ...
http://www.bioportfolio.com/gene/4353-MPO.html...
|
BioPortfolio - mit(1)15 - mitotic 15
Page 1 1 Cardio MPO TM Control Kit Catalog Number: 8601 to be used ... befolgen, um einen Kontakt mit Haut und Schleimhäuten zu vermeiden. 1,2. ...
http://www.bioportfolio.com/gene/47874-mit(1)15.html...
|
BioPortfolio - vih - vihar
Page 1 1 Cardio MPO TM Control Kit Catalog Number: 8601 to be used ... certeza de la ausencia del VIH-1, el VIH-2, el virus de la hepatitis B o .... le ...
http://www.bioportfolio.com/gene/44118-vih.html...
|
BioPortfolio - dei - delilah
Page 1 1 Cardio MPO TM Calibrator Kit Catalog Number: 9601 to be ... L’uso dei calibratori č progettato per garantire l’accuratezza dei risultati . ...
http://www.bioportfolio.com/gene/43190-dei.html...
|
BioPortfolio - Ten-m - Tenascin major
Page 1 Cardio MPO TM Enzyme Immunoassay Reagent Kit Catalog Number ... ten M. iu . rt. von 100,7 %. Wiederfindung nach Verdünnu. setzten Probe durch die ...
http://www.bioportfolio.com/gene/40464-Ten-m.html...
|
BioPortfolio - Triconex Corporate - Profile
SmartBrief: Nov 8 2008 3:05AM Matching: corporate. • Inverness Medical Innovations, PrognostiX Sign Distribution Agreement for CardioMPO Test ...
http://www.bioportfolio.com/biocorporate/31244-Triconex%2525...
|
Results from other life science and pharmaceutical sites:
FDA Approvals: PLAC, CardioMPO, HemosIL
Myeloperoxidase Test (CardioMPO) Predicts Risk of Myocardial Infarction. On May 10, the FDA approved an enzyme-linked immunosorbent assay (CardioMPO, ...
http://www.medscape.com/viewarticle/507691...
|
510(k) Summary PrognostiX CardioMPO r Test
The CardioMPO Test is an enzyme immunoassay intended for the ... The CardioMPO Test is a sandwich enzyme immunoassay that uses two highly specific ...
http://www.fda.gov/cdrh/pdf5/K050029.pdf...
|
Inverness Medical Innovations, PrognostiX Sign Distribution ...
"The CardioMPO(TM) Test is a great addition to our portfolio of cardiology ... The company's CardioMPO(TM) test, which aids in the diagnosis of near-term ...
http://biz.yahoo.com/prnews/081104/ne43764.html...
|
Inverness Medical Innovations, PrognostiX Sign Distribution ...
The CardioMPO(TM) Test, the only FDA-cleared diagnostic of its kind, measures myeloperoxidase, or MPO, an enzyme found in the blood. ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=...
|
CardioMPO predicts heart attack risk
“Receiving FDA approval to market the blood test under the name CardioMPO is a major milestone for the company and The Cleveland Clinic,” said Christopher ...
https://ccf.org/heartcenter/pub/news/archive/2005/cardiompo6...
|
BioPortfolio - PrognostiX, Inc.
PrognostiX is marketing the CardioMPO™ ELISA based test kit for in vitro diagnostic use. The CardioMPO™ Test measures myeloperoxidase (MPO) levels in
human ...
http://www.bioportfolio.com/biocorporate/28683-PrognostiX,_I...
|
1 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ...
The CardioMPO™ Test is comprised of the CardioMPO Reagent Kit, the. CardioMPO Calibrator Kit, and the CardioMPO Control Kit. The CardioMPO Reagent Kit is an
...
http://www.fda.gov/cdrh/reviews/K050029.pdf...
|
Prognostix Appoints Diagnostics Industry Veteran Orville President ...
The company’s CardioMPO™ test, which aids in the diagnosis of near-term heart attack and cardiac death risk, is the first FDA-cleared diagnostic of its kind
...
http://biz.yahoo.com/bw/081016/20081016005998.html?.v=1...
|
Facilitating Medical Innovation and Technology: The Role of FDA
Prognostix CardioMPO™ Test. Cardiovascular. Page 6. 6. Indications for use. diaDexis PLAC™ Test. Page 7. 7. Indications for use. Prognostix CardioMPO™ Test
...
http://www.fda.gov/OHRMS/DOCKETS/ac/06/slides/2006-4263s1_01...
|
PrognostiX, Inc. Appoints Diagnostics Industry Veteran Orville...
16 Oct 2008 ... The company’s CardioMPO™ test, which aids in the diagnosis of near-term heart attack and cardiac death risk, is the first FDA-cleared ...
http://www.biospace.com/news_story.aspx?NewsEntityId=113351...
|
|
